CenterWatch
Skip to content
Search Clinical Trials
Clinical Trial Listings
Volunteer
Learn About Clinical Trials
Ad Dammam, Saudi Arabia
Search
Location
Distance
< 2 Miles
search
Actively Recruiting
Disclaimer
Clear Filters
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
Phase
3
Span
276 weeks
Sponsor
AbbVie
Ad Dammam
Recruiting
READ MORE
1-1 of 1
keyboard_double_arrow_left
arrow_right_alt
1
arrow_right_alt
keyboard_double_arrow_right